Division of Sports Medicine Surgery, Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, Illinois, U.S.A.
Division of Sports Medicine Surgery, Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, Illinois, U.S.A.
Arthroscopy. 2020 Mar;36(3):734-742.e2. doi: 10.1016/j.arthro.2019.09.028. Epub 2019 Nov 14.
To (1) define Substantial Clinical Benefit (SCB), Patient Acceptable Symptomatic State (PASS), and Minimal Clinically Important Difference (MCID) for the visual analog scale (VAS) Satisfaction in patients undergoing hip arthroscopy for femoroacetabular impingement syndrome (FAIS), and (2) identify preoperative predictors of achieving each outcome end-point.
Data from consecutive patients who underwent primary hip arthroscopy between November 2014 and January 2017 were prospectively collected and retrospectively analyzed. Inclusion criteria consisted of patients with clinical and radiographic diagnosis of FAIS, who failed nonoperative treatment, underwent primary hip arthroscopy to address the FAIS, and had at minimum 2-year follow-up. Baseline data and postoperative patient-reported outcome scores were recorded at 2 years postoperatively. To quantify clinical significance of outcome achievement on the VAS)Satisfaction, we calculated MCID, PASS, and SCB for this outcome measure. A multivariate logistic regression analysis was used to identify preoperative predictors of achieving SCB, PASS, and MCID satisfaction.
A total of 335 patients were included in the final analysis, with an average age and body mass index (BMI) of 32.8 (standard deviation ± 12.4) years and 25.2 (standard deviation ± 5.3), respectively, and the majority being female (69.3%). The values on the VAS satisfaction were identified to represent MCID, PASS, and SCB, respectively: 52.8, 80.9, and 89.7. The rates of achieving clinically significant improvement on the VAS Satisfaction was 85.6%, 68.1%, and 56.9% for MCID, PASS, and SCB, respectively. A larger preoperative alpha angle was predictive for achieving SCB (odds ratio [OR], 1.076; P = .046), whereas lower BMI (OR, 0.955; P = .047) and larger preoperative alpha angle (OR, 1.12; P = .025) were predictors for achieving PASS.
This study identified threshold VAS satisfaction scores of 52.8, 80.9, and 89.7 for achieving MCID, SCB, and PASS, respectively, at 2-year follow-up following hip arthroscopy for FAIS. Furthermore, preoperative variables including larger preoperative alpha angles and lower BMI are predictors of achieving superior clinical satisfaction.
Level IV, Case Series.
(1)定义髋关节镜治疗股骨髋臼撞击综合征(FAIS)患者视觉模拟量表(VAS)满意度的大量临床获益(SCB)、患者可接受的症状状态(PASS)和最小临床重要差异(MCID),(2)确定达到每个终点的术前预测因素。
前瞻性收集 2014 年 11 月至 2017 年 1 月期间行初次髋关节镜治疗的连续患者的数据,并进行回顾性分析。纳入标准为:临床和影像学诊断为 FAIS、非手术治疗失败、行初次髋关节镜治疗 FAIS、且至少随访 2 年的患者。术后 2 年记录基线数据和术后患者报告的结果评分。为了量化 VAS 满意度结果的临床意义,我们为此测量结果计算了 MCID、PASS 和 SCB。使用多变量逻辑回归分析确定达到 SCB、PASS 和 MCID 满意度的术前预测因素。
最终分析共纳入 335 例患者,平均年龄和体重指数(BMI)分别为 32.8(标准差±12.4)岁和 25.2(标准差±5.3),其中大多数为女性(69.3%)。VAS 满意度的数值分别代表 MCID、PASS 和 SCB,分别为:52.8、80.9 和 89.7。在 VAS 满意度方面,达到临床显著改善的比例分别为 MCID、PASS 和 SCB:85.6%、68.1%和 56.9%。术前较大的阿尔法角与达到 SCB 相关(比值比[OR],1.076;P=.046),而较低的 BMI(OR,0.955;P=.047)和较大的术前阿尔法角(OR,1.12;P=.025)是达到 PASS 的预测因素。
本研究确定髋关节镜治疗 FAIS 后 2 年随访时,VAS 满意度分别达到 52.8、80.9 和 89.7 可分别实现 MCID、SCB 和 PASS。此外,术前变量,包括较大的术前阿尔法角和较低的 BMI,是达到更高临床满意度的预测因素。
IV 级,病例系列研究。